The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation

Learning and Memory

Volumn 16, Issue 9, 2009, Pages 537-544

  Wang, Yan ^a,b   Zhang, Ming ^a   Moon, Changjong ^c   Hu, Qubai ^d   Wang, Baiping ^d   Martin, George ^d   Sun, Zhongsheng ^b   Wang, Hongbing ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b INSTITUTE OF PSYCHOLOGY   (China)

^c Chonnam National University   (South Korea)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN FE65; PHOSPHODIESTERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; ENZYME ACTIVITY; FEAR; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; LONG TERM POTENTIATION; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SHORT TERM MEMORY; SYNAPSE; TRAINING;

ADAPTATION, PHYSIOLOGICAL; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BIOPHYSICS; CONDITIONING, CLASSICAL; ELECTRIC STIMULATION; FEAR; HIPPOCAMPUS; LEARNING DISORDERS; LONG-TERM POTENTIATION; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHODIESTERASE INHIBITORS; RNA, SMALL INTERFERING; ROLIPRAM; SIGNAL TRANSDUCTION;

EID: 69749090759     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.1499309     Document Type: Article

References (50)

1. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E. 1998. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci 95: 15020-15025. (Pubitemid 29003749)
2. Bhargava A, Dallman MF, Pearce D, Choi S. 2004. Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides. Brain Res Brain Res Protoc 13: 115-125. (Pubitemid 38692644)
3. Borg JP, Ooi J, Levy E, Margolis B. 1996. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16: 6229-6241. (Pubitemid 26360983)
4. Bork P, Margolis B. 1995. A phosphotyrosine interaction domain. Cell 80: 693-694.
5. Bressler SL, Gray MD, Sopher BL, Hu Q, Hearn MG, Pham DG, Dinulos MB, Fukuchi K, Sisodia SS, Miller MA, et al. 1996. cDNA cloning and chromosome mapping of the human Fe65 gene: Interaction of the conserved cytoplasmic domains of the human b-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet 5: 1589-1598. (Pubitemid 26328875)
6. Cao X, Sudhof TC. 2001. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293: 115-120. (Pubitemid 32801531)
7. Chen HI, Sudol M. 1995. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci 92: 7819-7823.
8. Costa RM, Honjo T, Silva AJ. 2003. Learning and memory deficits in Notch mutant mice. Curr Biol 13: 1348-1354. (Pubitemid 36953310)
9. Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC. 2004. Advanced transfection with Lipofectamine 2000 reagent: Primary neurons, siRNA, and high-throughput applications. Methods 33: 95-103. (Pubitemid 38569654)
10. Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, et al. 1999. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the b-amyloid precursor protein. Neuroscience 90: 1-13. (Pubitemid 29096448)
11. Ermekova KS, Zambrano N, Linn H, Minopoli G, Gertler F, Russo T, Sudol M. 1997. The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J Biol Chem 272: 32869-32877. (Pubitemid 28023623)
12. Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. 1995. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 270: 30853-30856. (Pubitemid 26012165)
13. Fischer DF, van Dijk R, Sluijs JA, Nair SM, Racchi M, Levelt CN, van Leeuwen FW, Hol EM. 2005. Activation of the Notch pathway in Down syndrome: Cross-talk of Notch and APP. FASEB J 19: 1451-1458. (Pubitemid 41279003)
14. Gavrila AM, Robinson B, Hoy J, Stewart J, Bhargava A, Amir S. 2008. Double-stranded RNA-mediated suppression of Period2 expression in the suprachiasmatic nucleus disrupts circadian locomotor activity in rats. Neuroscience 154: 409-414.
15. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. 2004. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114: 1624-1634. (Pubitemid 40385553)
16. Guenette SY, Chen J, Jondro PD, Tanzi RE. 1996. Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein. Proc Natl Acad Sci 93: 10832-10837. (Pubitemid 26333075)
17. Guenette S, Chang Y, Hiesberger T, Richardson JA, Eckman CB, Eckman EA, Hammer RE, Herz J. 2006. Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J 25: 420-431. (Pubitemid 43152862)
18. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, et al. 2000. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20: 7951-7963. (Pubitemid 30804644)
19. Herard AS, Besret L, Dubois A, Dauguet J, Delzescaux T, Hantraye P, Bonvento G, Moya KL. 2006. siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol Aging 27: 1740-1750. (Pubitemid 44572585)
20. Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW. 2006. FE65 interaction with the ApoE receptor ApoEr2. J Biol Chem 281: 24521-24530. (Pubitemid 44274227)
21. Hu Q, Jin LW, Starbuck MY, Martin GM. 2000. Broadly altered expression of the mRNA isoforms of FE65, a facilitator of b amyloidogenesis, in Alzheimer cerebellum and other brain regions. J Neurosci Res 60: 73-86. (Pubitemid 30176751)
22. Hu Q, Cool BH, Wang B, Hearn MG, Martin GM. 2002. A candidate molecular mechanism for the association of an intronic polymorphism of FE65 with resistance to very late onset dementia of the Alzheimer type. Hum Mol Genet 11: 465-475. (Pubitemid 34213620)
23. Ikin AF, Sabo SL, Lanier LM, Buxbaum JD. 2007. A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching. Mol Cell Neurosci 35: 57-63.
24. Kesavapany S, Banner SJ, Lau KF, Shaw CE, Miller CC, Cooper JD, McLoughlin DM. 2002. Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience 115: 951-960. (Pubitemid 35336035)
25. Kimberly WT, Esler WP, Ye W, Ostaszewski BL, Gao J, Diehl T, Selkoe DJ, Wolfe MS. 2003. Notch and the amyloid precursor protein are cleaved by similar g-secretase(s). Biochemistry 42: 137-144. (Pubitemid 36083860)
26. Kinoshita A, Whelan CM, Smith CJ, Mikhailenko I, Rebeck GW, Strickland DK, Hyman BT. 2001. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: Role of the intracellular adapter protein Fe65. J Neurosci 21: 8354-8361. (Pubitemid 33051433)
27. Krishnan V, Graham A, Mazei-Robison MS, Lagace DC, Kim KS, Birnbaum S, Eisch AJ, Han PL, Storm DR, Zachariou V, et al. 2008. Calcium-sensitive adenylyl cyclases in depression and anxiety: Behavioral and biochemical consequences of isoform targeting. Biol Psychiatry 64: 336-343.
28. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, DeBoer SR, Koliatsos VE, Kins S, Lee VM, Wong PC, et al. 2005. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: Revisited. J Neurosci 25: 2386-2395. (Pubitemid 40322280)
29. McLoughlin DM, Miller CC. 2008. The FE65 proteins and Alzheimer's disease. J Neurosci Res 86: 744-754.
30. Morris RG, Garrud P, Rawlins JN, O'Keefe J. 1982. Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683.
31. Muller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, Kogel D, Prehn JH, Egensperger R. 2007. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18: 201-210. (Pubitemid 46066721)
32. Muller T, Meyer HE, Egensperger R, Marcus K. 2008. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog Neurobiol 85: 393-406.
33. Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O. 2008. Picomolar amyloid-b positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28: 14537-14545.
34. Sabo SL, Lanier LM, Ikin AF, Khorkova O, Sahasrabudhe S, Greengard P, Buxbaum JD. 1999. Regulation of b-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem 274: 7952-7957. (Pubitemid 129518189)
35. Sabo SL, Ikin AF, Buxbaum JD, Greengard P. 2003. The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci 23: 5407-5415. (Pubitemid 36807814)
36. Schroeter EH, Kisslinger JA, Kopan R. 1998. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393: 382-386. (Pubitemid 28269713)
37. Seabrook GR, Smith DW, Bowery BJ, Easter A, Reynolds T, Fitzjohn SM, Morton RA, Zheng H, Dawson GR, Sirinathsinghji DJ, et al. 1999. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38: 349-359. (Pubitemid 29097718)
38. Suzuki T, Araki Y, Yamamoto T, Nakaya T. 2006. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis. J Biochem 139: 949-955. (Pubitemid 44196871)
39. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. 2002. Amyloid b-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci 99: 13217-13221.
40. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U. 2004. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117: 4435-4448. (Pubitemid 39360070)
41. Wang B, Hu Q, Hearn MG, Shimizu K, Ware CB, Liggitt DH, Jin LW, Cool BH, Storm DR, Martin GM. 2004a. Isoform-specific knockout of FE65 leads to impaired learning and memory. J Neurosci Res 75: 12-24. (Pubitemid 38049402)
42. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP, Furukawa K. 2004b. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci 101: 9458-9462. (Pubitemid 38812896)
43. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277: 39944-39952. (Pubitemid 35190981)
44. Wiltgen BJ, Sanders MJ, Anagnostaras SG, Sage JR, Fanselow MS. 2006. Context fear learning in the absence of the hippocampus. J Neurosci 26: 5484-5491.
45. Wong ST, Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, Muglia LJ, Storm DR. 1999. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 23: 787-798. (Pubitemid 29411567)
46. Yang Z, Cool BH, Martin GM, Hu Q. 2006. A dominant role for FE65 (APBB1) in nuclear signaling. J Biol Chem 281: 4207-4214. (Pubitemid 43847849)
47. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, De Candia P, De Renzis S, Faraonio R, Sabo S, Cheetham J, Sudol M, et al. 1997. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's β-amyloid precursor proteins. J Biol Chem 272: 6399-6405. (Pubitemid 27118118)
48. Zambrano N, Minopoli G, de Candia P, Russo T. 1998. The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273: 20128-20133. (Pubitemid 28377569)
49. Zhang M, Moon C, Chan GC, Yang L, Zheng F, Conti AC, Muglia L, Muglia LJ, Storm DR, Wang H. 2008. Ca-stimulated type 8 adenylyl cyclase is required for rapid acquisition of novel spatial information and for working/episodic-like memory. J Neurosci 28: 4736-4744.
50. Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G. 2000. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20: 542-549. (Pubitemid 30225556)